Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

CV 202-010 (DUSIN). A double-blind, placebo-controlled, randomized, two-stage, parallel-group, adaptive design phase 2a study to evaluate the effects of BMS-813160 (CCR2 and CCR5 receptor antagonist) in subjects with type 2 diabetes and DKD, who have residual macroalbuminuria despite treatment with inhibitor of the RAS system

Project: Types of projectsProject

  1. Sleep apnea in type 1 diabetes – SAP1 study

    Project: Types of projectsProject

View graph of relations

ID: 44812713